The Bribery Act came into force on 1 July 2011. The act makes it an offence for
a UK citizen or resident to pay or receive a bribe, either directly or indirectly.
The act provides for transactions that take place in the UK and abroad, and both
in the public and private sectors.
Companies and partnerships can also commit an offence where a bribe has been paid
on their behalf by an associate. Associates include employees, agents and other
persons providing services on behalf of the business entity. However, it is a defence
for the business if it has adequate procedures in place to prevent bribery.
The act creates three main offences:
- bribing a person to induce or reward them to perform a relevant function
- improperly requesting, accepting or receiving a bribe as a reward for performing
a relevant function
- improperly using a bribe to influence a foreign official to gain a business advantage.
The relevant function referred to can be an activity associated with the private
or public sector provided that the function should be carried out in either good
faith, impartially or that the person performing it is in a position of trust. Improper
performance of a relevant function would be a failure to perform it in line with
the relevant expectation. The test for whether performance was improper is what
a reasonable person in the UK would expect.
While acknowledging that the scope for bribery and corruption in a company such
as Apex Medici is limited and/or mitigated by other procedures, the Directors fully
appreciate the importance of suitable controls to prevent any possibility of bribery
and corruption within its operation or by any person associated with the Company.
They also want to actively promote a culture based on a commitment to acting professionally,
fairly and with integrity in which bribery & corruption is not permitted or condoned
in any manner.
The purpose of this policy is to set out the company’s approach to upholding these
principles.